ANALYTICAL SERVICES CENTER FOR MEDICATIONS DEVELOPMENT PROGRAM Release Date: July 1, 2002 NOTICE: NOT-DA-03-020 RFP AVAILABLE: N01DA-3-8829 National Institute on Drug Abuse (NIDA) The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified organizations having in-house capability to perform: (a) bio-analytical methods development and validation (b) quantitative drug analyses in biological specimens (c) federal good laboratory compliance requirements and (d) shipping and handling of biological specimens. NIDA and NIDA sponsored investigators use the data obtained for submissions to the FDA. The reports shall be adequate in format and substance for submission to the FDA in support of IND and NDA applications. Offerors must indicate possession of current DEA registration for Schedule II-V substances prior to award and apply for Schedule I registration at the time of award. NIDA anticipates the award of a 5 year incrementally funded completion- type contract with optional quantities from this procurement. All offerors must comply with the FDA's Good Laboratory Practices Program. NIDA anticipates the release of RFP No. N01DA-3-8829 on or about July 15, 2002, with responses due 45 calendar days thereafter. Offerors can access the RFP through the FedBizOpps (URL: http://www.fedbizopps.gov or through the NIDA website at the following address: (URL: http://www.nida.nih.gov/RFP/RFPList.html). NIDA will issue a streamlined RFP for this acquisition. Streamlined RFPs include only the Work Statement, Deliverables, Reporting Requirements, Special Requirements, Mandatory Qualifications, Technical Evaluation Criteria, and other necessary Proposal Preparation Instructions. The streamlined RFP contains all the information required for the submission of an offer. Following proposal submission and the initial review process, the Contracting Officer may require additional documentation from offerors comprising the competitive range. The due date for responses to the RFP is on or about August 29, 2002. This advertisement does not commit the Government to award a contract. Point of Contact: Michelle L. Scala, Contract Specialist National Institute on Drug Abuse, NIH Contracts Management Branch, OPRM 6001 Executive Boulevard Room 3105, MSC 9543 Bethesda, Maryland 20892-9543 Electronic Mail Address: ms35n@nih.gov Telephone: (301) 443-6677 Fax: (301) 443-7595
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |